EMJ | Elevating the quality of healthcare globally

This site is intended for healthcare professionals

Continue

Latest News

All News
syncope PFO closure
Interventional Cardiology
2 Jun 2026

Machine Learning Predicts Syncope Recurrence After PFO Closure

A machine-learning model accurately predicted syncope recurrence after PFO closure, potentially helping clinicians identify high-risk patients earlier.
General Healthcare
2 Jun 2026

NHS Catches Lung Cancer Early Through Supermarket Scans

More than 10,000 lung cancers have been detected through the NHS Lung Cancer Screening Programme, rolled out in supermarket car parks, sports stadiums, and busy high streets.
Chronic kidney disease
Nephrology
2 Jun 2026

Survival Risks in Chronic Kidney Disease

A cross-section study from Romania found that sarcopenia and obesity work additively rather that synergistically to increase mortality risk in older adults with chronic kidney disease.
General Healthcare
2 Jun 2026

High Prevalence of Depression Among Women with Cervical Cancer

More than one in three patients with cervical cancer are estimated to have depression globally, a new systematic review and meta-analysis has found.
Irritable bowel syndrome
Gastroenterology
2 Jun 2026

Herbal Preparation Reveals Benefits for Irritable Bowel Syndrome

Herbal preparation of myrrh, chamomile extract and coffee charcoal shown to provide benefits for those with irritable bowel syndrome.
genome sequencing
Innovations
2 Jun 2026

Two DNA Sequencing Platforms Show Similar Performance

Whole-genome sequencing technologies show comparable accuracy in variant detection, though researchers identify context-dependent differences in sequencing performance across challenging genomic regions.
Cellular therapy
Hematology
2 Jun 2026

EBMT Survey Reports Record Allogeneic Transplant Activity

The 2024 EBMT activity survey showed record allogeneic transplant numbers and continued expansion of CAR T therapy across Europe and affiliated countries.
Oncology
1 Jun 2026

Cancer Risk Prediction Highlights Screening Inequalities

Individualised cancer risk models revealed marked variation in lifetime and 10-year cancer risk, with healthy behaviours associated with substantial risk reduction.
Phase 3 Trial Supports Ecopipam for Tourette Syndrome
Neurology
1 Jun 2026

Phase 3 Trial Supports Ecopipam for Tourette Syndrome

A phase 3 trial has found ecopipam reduces relapse risk and maintains tic improvement in children and adolescents with Tourette syndrome.

Latest Articles

Interactive Content

Nephrology
28 May 2026

Why Are You Avoiding Peritoneal Dialysis in Patients with Prior Abdominal Surgery?

This interactive case study allows clinicians to examine a patient who has had major abdominal surgery and explore the considerations…
Nephrology
26 May 2026

Maintaining Lung-Protective Ventilation in ARDS

In acute respiratory distress syndrome management, maintaining lung protective ventilation can be challenged by rising CO2 levels and…
Respiratory
19 May 2026

IL-33 Is Not Just IL-33: There Is More Than One Side to the COPD Story

COPD exacerbations place a considerable burden on patients and healthcare systems.1-3 Even with optimised maintenance therapy, many…
Hepatology
15 Apr 2026

MASH and The Race for Liver Antifibrotics

Metabolic dysfunction-associated steatohepatitis (MASH), along with other chronic liver diseases, leads to progressive fibrosis and…
All Interactive Content

Latest Infographics

All Infographics
Microbiology & Infectious Diseases
30 Apr 2026

HIV at a Crossroads: Innovation and Inequity

This infographic presents the current landscape of HIV care at a crossroads, where rapid advances in long-acting prevention and treatment..
CAMCEVI® (leuprolide mesylate) 42 mg Injectable Emulsion: Ready-to-Use Innovation in Androgen Deprivation Therapy
Urology
23 Apr 2026

Ready-to-Use Innovation in Androgen Deprivation Therapy

Androgen deprivation therapy (ADT) is essential in advanced prostate cancer but often requires complex, multi-step preparations…
Oncology
17 Apr 2026

The Importance of BRAF Testing in NSCLC

BRAF mutations are rare, occurring in around 2-4% of patients with NSCLC. Around 50% of BRAF mutations are BRAFV60 mutations, which mostly…
Reproductive Health
10 Apr 2026

Individualising MHT and its Impact on Long-term Health

MHT is the most effective treatment for the management of oestrogen deficiency symptoms and has been shown to prevent bone loss and…

Latest Podcasts

All Podcasts
Oncology
2 Jun 2026

Onc Now: Inside Lung Cancer Care and What Comes Next

In this episode of Onc Now, Paolo Bironzo joins us to discuss the evolving landscape of thoracic oncology and the innovations…
Sex Differences in Alzheimer’s Disease
Neurology
1 Jun 2026

Sex Differences in Alzheimer’s Disease

In this series, host Catherine Glass speaks with Rachel Buckley about how Alzheimer’s disease risk and progression…
Microbiology & Infectious Diseases
29 May 2026

How to Combat AMR: The Most Promising Solutions

Antimicrobial resistance (AMR) represents one of the most pressing threats to global health, with projections suggesting it could claim….
Victor Garcia
Oncology
27 May 2026

Onc Now: AI, Immunotherapy, and the Next Wave of Cancer Trials

In this episode of Onc Now, we explore the challenges of translating early-phase oncology research into meaningful clinical benefit…

Latest Videos & Webinars

All Videos & Webinars
General Healthcare
28 May 2026

WHA Congress Wrap

The 79th Annual World Health Assembly was held at the United Nations Office in Geneva, Switzerland. Member States of the WHO convened to…
Microbiology & Infectious Diseases
27 May 2026

How Sequencing is Reshaping Infectious Disease Genomics

Antimicrobial resistance, outbreak investigation, and pathogen surveillance present growing challenges for clinical microbiology…
EMJ
Rheumatology
22 May 2026

IL-1 in Focus: An Expert Question and Answer Session

Sobi has launched a four-part podcast series featuring leading experts in rheumatology, exploring the role of IL-1 in…
We’ve noticed you’re accessing
from North/South America.